Literature DB >> 19430717

Unbalanced expression of protease-activated receptors-1 and -2 in the colon of diarrhea-predominant irritable bowel syndrome patients.

Zhao Xiang Bian1, Zhi Li, Zhi Xin Huang, Man Zhang, Hong Li Chen, Hong Xi Xu, Joseph J Y Sung.   

Abstract

OBJECTIVE: The aim of this study is to determine whether a changed expression ratio of PAR-1 and PAR-2 in the colon is associated with diarrhea-predominant IBS patients.
METHODS: PAR-1, -2, thrombin, mast cell tryptase, tryptophan hydroxylase (TPH), and chromgranin A (ChrA) in colonic biopsy samples from 10 diarrhea-predominant IBS patients and 13 healthy control subjects were semiquantified with immunofluorescence and image analysis. Serotonin concentrations in biopsy samples were evaluated by capillary electrophoresis.
RESULTS: Significantly lower expression of PAR-1 and higher expression of mast cell tryptase was detected in the colons of patients, with statistically unchanged expression of PAR-2. Thrombin-, TPH-, and ChrA-positive cells were markedly increased in IBS patients, but no significant difference in serotonin concentration existed in the colons between two groups. The ratio of PAR-1/PAR-2 expression was significantly decreased in patients (0.33+/-0.19 versus 0.66+/-0.22, P=0.001) and negatively correlated to ChrA-positive cells.
CONCLUSIONS: Changed expression ratio of PAR-1 to PAR-2 in the colon is connected with diarrhea-predominant IBS patients. Methods to restore an appropriate balance of PAR-1 and PAR-2 activation in the colon may offer a promising future therapeutic strategy for IBS patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19430717     DOI: 10.1007/s00535-009-0058-2

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  32 in total

1.  Modulation of capsaicin-evoked visceral pain and referred hyperalgesia by protease-activated receptors 1 and 2.

Authors:  Naoyuki Kawao; Hisao Ikeda; Tomoko Kitano; Ryotaro Kuroda; Fumiko Sekiguchi; Kazuo Kataoka; Yoshihisa Kamanaka; Atsufumi Kawabata
Journal:  J Pharmacol Sci       Date:  2004-03       Impact factor: 3.337

2.  Expression of protease-activated receptors 1 and 2 in melanocytic nevi and malignant melanoma.

Authors:  Daniela Massi; Antonella Naldini; Camilla Ardinghi; Fabio Carraro; Alessandro Franchi; Milena Paglierani; Francesca Tarantini; Sheyda Ketabchi; Giuseppe Cirino; Morley D Hollenberg; Pierangelo Geppetti; Marco Santucci
Journal:  Hum Pathol       Date:  2005-06       Impact factor: 3.466

3.  Proteinase-activated receptor-2 and hyperalgesia: A novel pain pathway.

Authors:  N Vergnolle; N W Bunnett; K A Sharkey; V Brussee; S J Compton; E F Grady; G Cirino; N Gerard; A I Basbaum; P Andrade-Gordon; M D Hollenberg; J L Wallace
Journal:  Nat Med       Date:  2001-07       Impact factor: 53.440

4.  Proteinases and proteinase-activated receptor 2: a possible role to promote visceral hyperalgesia in rats.

Authors:  Anne-Marie Coelho; Nathalie Vergnolle; Bruno Guiard; Jean Fioramonti; Lionel Bueno
Journal:  Gastroenterology       Date:  2002-04       Impact factor: 22.682

5.  Role for protease activity in visceral pain in irritable bowel syndrome.

Authors:  Nicolas Cenac; Christopher N Andrews; Marinella Holzhausen; Kevin Chapman; Graeme Cottrell; Patricia Andrade-Gordon; Martin Steinhoff; Giovanni Barbara; Paul Beck; Nigel W Bunnett; Keith A Sharkey; Jose Geraldo P Ferraz; Eldon Shaffer; Nathalie Vergnolle
Journal:  J Clin Invest       Date:  2007-02-15       Impact factor: 14.808

6.  Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome.

Authors:  R C Spiller; D Jenkins; J P Thornley; J M Hebden; T Wright; M Skinner; K R Neal
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

7.  Thrombin inhibits NMDA-mediated nociceptive activity in the mouse: possible mediation by endothelin.

Authors:  Ming Fang; Katalin J Kovács; Lauralei L Fisher; Alice A Larson
Journal:  J Physiol       Date:  2003-04-25       Impact factor: 5.182

8.  Proteinase-activated receptor-1 agonists attenuate nociception in response to noxious stimuli.

Authors:  Samuel Asfaha; Valentine Brussee; Kevin Chapman; Douglas W Zochodne; Nathalie Vergnolle
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

Review 9.  Irritable bowel syndrome: a little understood organic bowel disease?

Authors:  Nicholas J Talley; Robin Spiller
Journal:  Lancet       Date:  2002-08-17       Impact factor: 79.321

Review 10.  Role of serotonin in the pathophysiology of the irritable bowel syndrome.

Authors:  Michael D Crowell
Journal:  Br J Pharmacol       Date:  2004-04       Impact factor: 8.739

View more
  15 in total

1.  Lesioning of TRPV1 expressing primary afferent neurons prevents PAR-2 induced motility, but not mechanical hypersensitivity in the rat colon.

Authors:  S K Suckow; E M Anderson; R M Caudle
Journal:  Neurogastroenterol Motil       Date:  2011-12-13       Impact factor: 3.598

2.  Gut pain & visceral hypersensitivity.

Authors:  Adam D Farmer; Qasim Aziz
Journal:  Br J Pain       Date:  2013-02

3.  The functional role of protease-activated receptors on contractile responses by activation of Ca2+ sensitization pathways in simian colonic muscles.

Authors:  Tae Sik Sung; Hongli Lu; Juno Sung; Jong Hoon Yeom; Brian A Perrino; Sang Don Koh
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-09-27       Impact factor: 4.052

4.  The expression of protease-activated receptor 2 and 4 in the colon of irritable bowel syndrome patients.

Authors:  Ju-hui Zhao; Lei Dong; Hai-tao Shi; Zong-yan Wang; Hong-yang Shi; Hui Ding
Journal:  Dig Dis Sci       Date:  2011-07-29       Impact factor: 3.199

5.  Association of symptoms with gastrointestinal microbiota in irritable bowel syndrome.

Authors:  Erja Malinen; Lotta Krogius-Kurikka; Anna Lyra; Janne Nikkilä; Anne Jääskeläinen; Teemu Rinttilä; Terttu Vilpponen-Salmela; Atte Johannes von Wright; Airi Palva
Journal:  World J Gastroenterol       Date:  2010-09-28       Impact factor: 5.742

Review 6.  Mucosal inflammation as a potential etiological factor in irritable bowel syndrome: a systematic review.

Authors:  Alexander C Ford; Nicholas J Talley
Journal:  J Gastroenterol       Date:  2011-02-18       Impact factor: 7.527

Review 7.  Mast cells: an expanding pathophysiological role from allergy to other disorders.

Authors:  Preet Anand; Baldev Singh; Amteshwar Singh Jaggi; Nirmal Singh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-05-06       Impact factor: 3.000

8.  Probiotics VSL#3 protect against development of visceral pain in murine model of irritable bowel syndrome.

Authors:  Eleonora Distrutti; Sabrina Cipriani; Andrea Mencarelli; Barbara Renga; Stefano Fiorucci
Journal:  PLoS One       Date:  2013-05-15       Impact factor: 3.240

9.  Transient early neurotrophin release and delayed inflammatory cytokine release by microglia in response to PAR-2 stimulation.

Authors:  Chen-Wen Chen; Qian-Bo Chen; Qing Ouyang; Ji-Hu Sun; Fang-Ting Liu; Dian-Wen Song; Hong-Bin Yuan
Journal:  J Neuroinflammation       Date:  2012-06-25       Impact factor: 8.322

Review 10.  Mast Cells and Irritable Bowel Syndrome: From the Bench to the Bedside.

Authors:  Lei Zhang; Jun Song; Xiaohua Hou
Journal:  J Neurogastroenterol Motil       Date:  2016-04-30       Impact factor: 4.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.